18364491

Source:http://linkedlifedata.com/resource/pubmed/id/18364491

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0162488, umls-concept:C2700205
pubmed:issue	12
pubmed:dateCreated	2008-3-26
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Azetidines, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/ezetimibe, http://linkedlifedata.com/resource/pubmed/chemical/torcetrapib
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1538-3598
pubmed:author	pubmed-author:LumleyThomasT, pubmed-author:PsatyBruce MBM
pubmed:issnType	Electronic
pubmed:day	26
pubmed:volume	299
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1474-6
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18364491-Azetidines, pubmed-meshheading:18364491-Biological Markers, pubmed-meshheading:18364491-Clinical Trials as Topic, pubmed-meshheading:18364491-Drug Approval, pubmed-meshheading:18364491-Humans, pubmed-meshheading:18364491-Hypolipidemic Agents, pubmed-meshheading:18364491-Quinolines, pubmed-meshheading:18364491-Risk, pubmed-meshheading:18364491-United States, pubmed-meshheading:18364491-United States Food and Drug Administration
pubmed:year	2008
pubmed:articleTitle	Surrogate end points and FDA approval: a tale of 2 lipid-altering drugs.
pubmed:affiliation	Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington 98101, USA. psaty@u.washington.edu
pubmed:publicationType	Journal Article